Healthcare > Eli Lilly

Tracking since May 19, 2026 · Latest signal Apr 20, 2026 · 4 matched data points

Overall sentiment

Positive 100% (4)Negative 0% (0)Neutral 0% (0)

Daily sentiment

Claims (1)

Claims contributing to this aggregate. Confirmed negative claims count as negative impact; confirmed positive claims count as positive impact.

Eli Lilly is nearing a deal to acquire Kelonia Therapeutics, a cancer biotech company.

Parent: HealthcareEntity: Eli LillySub-entity: Acquisition of Kelonia TherapeuticsImpact: positiveDate: Apr 19, 2026 - Apr 20, 2026Target: Eli Lilly's acquisition of Kelonia Therapeutics4 matched entries4 confirmed0 disputed0 neutral0 unclear